Corpremans Clinical Trial Consultancy ABActive
Key figures
Key figures
2025Balance structure
Dividend
proposedProposed dividend 400 000 kr.
Taken directly from the proposed appropriation of profit in the annual report (not calculated).
Summary of annual reports2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Balance sheet — assets | ||||
| Total current assets | 821 110 | 1 282 972 | 2 283 888 | 2 443 380 |
| Total non-current assets | — | — | — | 535 000 |
| Total assets | 821 110 | 1 282 972 | 2 283 888 | 2 978 380 |
| Balance sheet — liabilities and equity | ||||
| Current liabilities | 174 708 | 324 282 | 607 073 | 637 347 |
| Non-current liabilities | 165 492 | 165 492 | 0 | — |
| Total liabilities | 475 200 | 804 774 | 1 222 073 | 1 552 347 |
| Share capital | 25 000 | 25 000 | 25 000 | 25 000 |
| Retained earnings of previous periods | — | — | — | — |
| Profit for the year (equity) | 320 910 | 432 288 | 983 617 | 764 218 |
| Total equity | 345 910 | 478 198 | 1 061 815 | 1 426 033 |
| Income statement | ||||
| Sales revenue | 1 351 243 | 1 564 594 | 4 057 730 | 4 425 467 |
| Operating profit | 539 361 | 711 889 | 2 329 857 | 1 550 323 |
| Profit before income tax | 404 867 | 546 072 | 1 248 741 | 971 958 |
| Profit for the reporting year | 320 910 | 432 288 | 983 617 | 764 218 |
| Labour costs | 670 987 | 616 049 | 1 136 653 | 2 309 197 |
| Depreciation of non-current assets | — | — | — | — |
| Other indicators | ||||
| Employees | 1 | 1 | 2 | 4 |
| Proposed dividend | — | 400 000 | 400 000 | 400 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Summary: Corpremans Clinical Trial Consultancy AB
Overview
Corpremans Clinical Trial Consultancy AB (org. no. 559363-4412) is a limited company (AB). The company was registered in 2022 and has existed for 4 years. Registered seat: Bjärred. Industry according to Statistics Sweden: other research and experimental development on natural sciences and engineering (SNI 72109).
Economy
Net sales in financial year 2025 were 4 425 467 kr, up 9,1 % on the previous year (4 057 730 kr). From 2022 to 2025, net sales grew by an average of 48,5 % per year. This is the highest net sales among the reported years (2022–2025). Net profit for 2025 was 764 218 kr (17,3 % of net sales). The company was profitable in all 4 reported financial years. Employees in financial year 2025: 4 (previous year: 2). Net sales per employee were 1 106 367 kr. At the end of financial year 2025, total assets were 2 978 380 kr and equity 1 426 033 kr (equity ratio 47,9 %). The annual report for 2025 proposes a dividend of 400 000 kr.
Sources and freshness
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-10-12. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.